Publications by authors named "Kayla Andrews"

Claim this Profile
H
Human monoclonal antibody MAM01 for protection against malaria in adults in the USA: a first-in-human, phase 1, dose-escalation, double-blind, placebo-controlled, adaptive trial.
Kirsten E Lyke, Andrea A Berry, Matthew B Laurens, Jennifer Winkler, Sudhaunshu Joshi, Kayla Andrews

Lancet Infect Dis· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.
Craig R Rayner, Patrick F Smith, David Andes, Kayla Andrews, Hartmut Derendorf

Clin Pharmacol Ther· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Analysis Using Pharmacokinetic/Pharmacodynamic Modeling and Simulation Offers Improvements in Efficiency of the Design of Volunteer Infection Studies for Antimalarial Drug Development.
Kayla Ann Andrews, Joel S Owen, James McCarthy, David Wesche, Nathalie Gobeau

Clin Transl Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Drug Development for Malaria Therapeutics.
Kayla Ann Andrews, David Wesche, James McCarthy, Jörg J Möhrle, Joel Tarning

Annu Rev Pharmacol Toxicol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis